PUREGON Side Effects

6253062-3 | Abortion Spontaneous, Cervical Incompetence, Injury, Pregnancy, Therapeutic Response Decreased
on Jun 12, 2009 Female patient from UNITED STATES , 42 years of age, was diagnosed with infertility (What is infertility?) and was treated with Puregon (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, cervical incompetence, injury, pregnancy (What is pregnancy?), therapeutic response decreased. Puregon dosage: .

6250124-1 | Joint Swelling, Oedema Peripheral, Pain In Extremity
Patient was taking Puregon (View Usage). Patient had the following side effects: joint swelling, oedema peripheral, pain in extremity on Jun 12, 2009 from UNITED STATES Additional patient health information: Female patient , 35 years of age, . Puregon dosage: 75 Iu Daily Subcutaneous.

6223070-7 | Abortion Spontaneous, Pregnancy Test Positive
Adverse event was reported on May 26, 2009 by a Female patient taking Puregon (View Usage) (Dosage: 300 Iu Daily Intramuscular) was diagnosed with ovarian disorder, luteal phase deficiency and. Location: JAPAN , 38 years of age, weighting 116.8 lb, After Puregon was administered, patient had the following side effects: abortion spontaneous, pregnancy test positive. During the same period patient was treated with PREGNYL (5000 Iu Once) (View Pregnyl Review and Pregnyl Label ), SUPRECUR (View Suprecur Review and Suprecur Label ), PROFASI HP (View Profasi Hp Review and Profasi Hp Label ), PROGEHORMON (View Progehormon Review and Progehormon Label ), PROGESTERONE VAGINAL (View Progesterone Vaginal Review and Progesterone Vaginal Label ), ESTRADERM (View Estraderm Review and Estraderm Label ). Patient was hospitalized.

6165630-8 | Ovarian Hyperstimulation Syndrome
on Sep 23, 2008 Female patient from UNITED STATES , 33 years of age, weighting 145.1 lb, was diagnosed with infertility (What is infertility?), ovulation induction and was treated with Puregon (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian hyperstimulation syndrome. Puregon dosage: 175 Iu Daily Subcutaneous. During the same period patient was treated with CHORIONIC GONADOTROPIN (10000 Iu) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ). Patient was hospitalized.


6165629-1 | Ovarian Hyperstimulation Syndrome
on Jun 11, 2008 Female patient from UNITED STATES , weighting 127.0 lb, was diagnosed with infertility (What is infertility?) and was treated with Puregon (View Usage). Patient had the following side effects: ovarian hyperstimulation syndrome. Puregon dosage: 150 Iu Daily. During the same period patient was treated with PREGNYL (650 Iu) (View Pregnyl Review and Pregnyl Label ), ORGALUTRAN (View Orgalutran Review and Orgalutran Label ), MENOPUR (View Menopur Review and Menopur Label ), LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ), ALBUMIN (HUMAN) (View Albumin (human) Review and Albumin (human) Label ).

6150777-2 | Ectopic Pregnancy
Patient was taking Puregon (View Usage). After Puregon was administered, patient had the following side effects: ectopic pregnancy on Mar 25, 2009 from JAPAN Additional patient health information: Female patient , 36 years of age, . Puregon dosage: Iu Alt Intramuscular. During the same period patient was treated with HCG5000 (View Hcg5000 Review and Hcg5000 Label ), CLOMID (View Clomid Review and Clomid Label ), SUPRECUR (View Suprecur Review and Suprecur Label ), DUPHASTON (View Duphaston Review and Duphaston Label ), JUVELA (View Juvela Review and Juvela Label ). Patient was hospitalized.

5727527-4 | Ectopic Pregnancy
Adverse event was reported on Jan 15, 2008 by a Female patient taking Puregon (View Usage) (Dosage: ) . Location: UNITED STATES , 21 years of age, Patient experienced the following unwanted or unexpected effects: ectopic pregnancy.

5727525-0 | Ovarian Hyperstimulation Syndrome
on Oct 12, 2007 Female patient from UNITED STATES , 40 years of age, weighting 130.3 lb, was diagnosed with assisted fertilisation and was treated with Puregon (View Usage). Patient had the following side effects: ovarian hyperstimulation syndrome. Puregon dosage: 525 Mg Daily Subcutaneous. During the same period patient was treated with MENOPUR (View Menopur Review and Menopur Label ), LUPRON (View Lupron Review and Lupron Label ).

5727518-3 | Ovarian Hyperstimulation Syndrome
on Aug 23, 2007 Female patient from UNITED STATES , 28 years of age, was treated with Puregon (View Usage). After Puregon was administered, patient had the following side effects: ovarian hyperstimulation syndrome. Puregon dosage: Total Dosage 2 July 2007 - 9 July 2007: 1150 Ui. During the same period patient was treated with GANIRELIX ACETATE INJECTION (View Ganirelix Acetate Injection Review and Ganirelix Acetate Injection Label ). Patient was hospitalized.

5727509-2 | Abortion Spontaneous
Patient was taking Puregon (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous on Aug 23, 2007 from UNITED STATES Additional patient health information: Female patient , 30 years of age, was diagnosed with infertility female and. Puregon dosage: . During the same period patient was treated with OVIDREL (View Ovidrel Review and Ovidrel Label ), LUPRON (View Lupron Review and Lupron Label ), MENOPUR (View Menopur Review and Menopur Label ).

5727494-3 | Ovarian Hyperstimulation Syndrome
Adverse event was reported on Jun 29, 2007 by a Female patient taking Puregon (View Usage) (Dosage: 150 Iu Qd Subcutaneous) was diagnosed with infertility male and. Location: UNITED STATES , 28 years of age, weighting 134.5 lb, Patient had the following side effects: ovarian hyperstimulation syndrome. During the same period patient was treated with CHORIONIC GONADOTROPIN (10000 Iu Once Subcutaneous) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ). Patient was hospitalized.

5637699-8 | Abortion Spontaneous
on Feb 08, 2008 Female patient from UNITED STATES , 38 years of age, weighting 129.5 lb, was diagnosed with ovarian hyperstimulation syndrome, blood luteinising hormone and was treated with Puregon (View Usage). After Puregon was administered, patient had the following side effects: abortion spontaneous. Puregon dosage: 150 Iu Daily Intramuscular. During the same period patient was treated with HUMEGON (150 Iu Daily Intramuscular) (View Humegon Review and Humegon Label ), PREGNYL (10000 Iu Once Intramuscular) (View Pregnyl Review and Pregnyl Label ), PREDONINE (View Predonine Review and Predonine Label ). Patient was hospitalized.

5528737-1 | Ovarian Hyperstimulation Syndrome
on Jun 29, 2007 Female patient from UNITED STATES , 28 years of age, weighting 134.5 lb, was diagnosed with infertility male and was treated with Puregon (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian hyperstimulation syndrome. Puregon dosage: 150 Iu Qd Subcutaneous. During the same period patient was treated with CHORIONIC GONADOTROPIN (10000 Iu Once Subcutaneous) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ). Patient was hospitalized.

5528736-X | Ovarian Hyperstimulation Syndrome
Patient was taking Puregon (View Usage). Patient had the following side effects: ovarian hyperstimulation syndrome on Jun 26, 2007 from UNITED STATES Additional patient health information: Female patient , 30 years of age, weighting 154.1 lb, was diagnosed with infertility (What is infertility?) and. Puregon dosage: 150 Iu Qd Subcutaneous, Premixed Vials. During the same period patient was treated with CHORIONIC GONADOTROPIN (10000 Iu Subcutaneous) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), REPRONEX (150 Iu Qd Subcutaneous) (View Repronex Review and Repronex Label ). Patient was hospitalized.

5528734-6 | Ovarian Hyperstimulation Syndrome
Adverse event was reported on Jun 26, 2007 by a Female patient taking Puregon (View Usage) (Dosage: 150 Iu Qd Subcutaneous, Premixed Vials) was diagnosed with anovulatory cycle and. Location: UNITED STATES , 32 years of age, weighting 128.0 lb, After Puregon was administered, patient had the following side effects: ovarian hyperstimulation syndrome. During the same period patient was treated with CHORIONIC GONADOTROPIN (10000 Iu Subcutaneous) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), REPRONEX (75 Iu Subcutaneous) (View Repronex Review and Repronex Label ). Patient was hospitalized.

5528733-4 | Ovarian Hyperstimulation Syndrome
on Jun 26, 2007 Female patient from UNITED STATES , 26 years of age, weighting 142.0 lb, was diagnosed with oocyte donation and was treated with Puregon (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian hyperstimulation syndrome. Puregon dosage: 150 Iu Qd Subcutaneous, Premixed Vials. During the same period patient was treated with CHORIONIC GONADOTROPIN (10000 Iu Subcutaneous) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), REPRONEX (75 Iu Qd Subcutaneous) (View Repronex Review and Repronex Label ). Patient was hospitalized.

5508718-4 | Deep Vein Thrombosis
on Oct 24, 2007 Female patient from UNITED STATES , 34 years of age, was diagnosed with in vitro fertilisation, ovulation induction and was treated with Puregon (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Puregon dosage: 450 Iu Daily Subcutaneous. During the same period patient was treated with ORGALUTRAN (Subcutaneous) (View Orgalutran Review and Orgalutran Label ), CHORIONIC GONADOTROPIN (10000 Iu Once Subcutaneous) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), PROMETRIUM (100 Mg Daily) (View Prometrium Review and Prometrium Label ), MENOPUR (75 Iu Daily Subcutaneous) (View Menopur Review and Menopur Label ), FEMTRACE (View Femtrace Review and Femtrace Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ). Patient was hospitalized.

5498434-X | Deep Vein Thrombosis
Patient was taking Puregon (View Usage). After Puregon was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?) on Oct 11, 2007 from UNITED STATES Additional patient health information: Female patient , 34 years of age, was diagnosed with in vitro fertilisation and. Puregon dosage: 450 Iu Daily. During the same period patient was treated with ORGALUTRAN (View Orgalutran Review and Orgalutran Label ), CHORIONIC GONADOTROPIN (10000 Iu Once) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), MENOPUR (75 Iu Daily) (View Menopur Review and Menopur Label ), FEMTRACE (View Femtrace Review and Femtrace Label ), PROMETRIUM (View Prometrium Review and Prometrium Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ). Patient was hospitalized.

5475480-3 | Ovarian Hyperstimulation Syndrome
Adverse event was reported on Jun 26, 2007 by a Female patient taking Puregon (View Usage) (Dosage: 150 Iu Qd Subcutaneous, Premixed Vials) . Location: UNITED STATES , 30 years of age, weighting 154.1 lb, Patient experienced the following unwanted or unexpected effects: ovarian hyperstimulation syndrome. During the same period patient was treated with CHORIONIC GONADOTROPIN (10000 Iu Subcutaneous) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), REPRONEX (150 Iu Qd Subcutaneous) (View Repronex Review and Repronex Label ). Patient was hospitalized.

5475479-7 | Ovarian Hyperstimulation Syndrome
on Jun 26, 2007 Female patient from UNITED STATES , 32 years of age, weighting 128.0 lb, was diagnosed with anovulatory cycle and was treated with Puregon (View Usage). Patient had the following side effects: ovarian hyperstimulation syndrome. Puregon dosage: 150 Iu Qd Subcutaneous, Premixed Vials. During the same period patient was treated with CHORIONIC GONADOTROPIN (10000 Iu Subcutaneous) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), REPRONEX (75 Iu Qd Subcutaneous) (View Repronex Review and Repronex Label ). Patient was hospitalized.

5475475-X | Ovarian Hyperstimulation Syndrome
on Jun 26, 2007 Female patient from UNITED STATES , 26 years of age, weighting 142.0 lb, was treated with Puregon (View Usage). After Puregon was administered, patient had the following side effects: ovarian hyperstimulation syndrome. Puregon dosage: 150 Iu Qd Subcutaneous, Premixed Vials. During the same period patient was treated with CHORIONIC GONADOTROPIN (10000 Iu Subcutaneous) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), REPRONEX (75 Iu Qd Subcutaneous) (View Repronex Review and Repronex Label ). Patient was hospitalized.

5475470-0 | Ovarian Hyperstimulation Syndrome
Patient was taking Puregon (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian hyperstimulation syndrome on Jun 26, 2007 from UNITED STATES Additional patient health information: Female patient , 34 years of age, weighting 126.0 lb, was diagnosed with infertility male and. Puregon dosage: 150 Iu Bid Subcutaneous, Premixe Vials. During the same period patient was treated with CHORIONIC GONADOTROPIN (5000 Iu Once Subcutaneous) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), MENOPUR (75 Iu Bid Subcutaneous) (View Menopur Review and Menopur Label ).

5397042-9 | Abortion Spontaneous
Adverse event was reported on Jul 05, 2007 by a Female patient taking Puregon (View Usage) (Dosage: Df) was diagnosed with infertility (What is infertility?) and. Location: UNITED STATES , 24 years of age, Patient had the following side effects: abortion spontaneous. During the same period patient was treated with HUMAN CHORIONIC GONADOTROPHIN (Df) (View Human Chorionic Gonadotrophin Review and Human Chorionic Gonadotrophin Label ).

5200185-3 | Abortion Induced, Ectopic Pregnancy, Pelvic Pain
on Dec 19, 2006 Female patient from UNITED STATES , 29 years of age, weighting 119.9 lb, was diagnosed with in vitro fertilisation and was treated with Puregon (View Usage). After Puregon was administered, patient had the following side effects: abortion induced, ectopic pregnancy, pelvic pain (What is pelvic pain?). Puregon dosage: 200 Iu Daily;. During the same period patient was treated with ORGALUTRAN (215 Ug, Daily;) (View Orgalutran Review and Orgalutran Label ). Patient was hospitalized.

5193894-6 | Abortion Induced, Ectopic Pregnancy
on Dec 12, 2006 Female patient from UNITED STATES , 29 years of age, weighting 119.9 lb, was diagnosed with in vitro fertilisation and was treated with Puregon (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced, ectopic pregnancy. Puregon dosage: 200 Ig Daily. During the same period patient was treated with ORGALUTRAN (215 Ug Daily) (View Orgalutran Review and Orgalutran Label ). Patient was hospitalized.

5186947-X | Ovarian Torsion
Patient was taking Puregon (View Usage). Patient had the following side effects: ovarian torsion on Nov 29, 2006 from UNITED STATES Additional patient health information: Female patient , 35 years of age, was diagnosed with ovulation induction and. Puregon dosage: . During the same period patient was treated with UHCG (1000 Iu Once Intramuscular) (View Uhcg Review and Uhcg Label ), ORGALUTRAN (View Orgalutran Review and Orgalutran Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), LIDOCAINE 1% (View Lidocaine 1% Review and Lidocaine 1% Label ).

5137067-1 | Trisomy 18
Adverse event was reported on May 15, 2006 by a Female patient taking Puregon (View Usage) (Dosage: ) . Location: CANADA , weighting 5.50 lb, After Puregon was administered, patient had the following side effects: trisomy 18. During the same period patient was treated with FOLLICLE STIMULATING HORMONE, RECOMBINANT (View Follicle Stimulating Hormone, Recombinant Review and Follicle Stimulating Hormone, Recombinant Label ), FEMARA (Maternal Dose: 2.5 Mg/day From Day 3 To 7) (View Femara Review and Femara Label ).

5118793-7 | Polyneuropathy
on Sep 15, 2006 Female patient from UNITED STATES , 41 years of age, was diagnosed with infertility (What is infertility?) and was treated with Puregon (View Usage). Patient experienced the following unwanted or unexpected effects: polyneuropathy. Puregon dosage: .

5032570-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Ovarian Hyperstimulation Syndrome
on Jun 09, 2006 Female patient from UNITED STATES , 25 years of age, was diagnosed with infertility (What is infertility?) and was treated with Puregon (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, ovarian hyperstimulation syndrome. Puregon dosage: . During the same period patient was treated with BROMOCRIPTINE MESYLATE (View Bromocriptine Mesylate Review and Bromocriptine Mesylate Label ), PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ), VAGINAL PROGESTERONE (View Vaginal Progesterone Review and Vaginal Progesterone Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

5030725-9 | Alanine Aminotransferase Increased, Ascites, Aspartate Aminotransferase Increased, Multigravida, Ovarian Cyst, Ovarian Hyperstimulation Syndrome
Patient was taking Puregon (View Usage). After Puregon was administered, patient had the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, multigravida, ovarian cyst (What is ovarian cyst?), ovarian hyperstimulation syndrome on Jun 06, 2006 from UNITED STATES Additional patient health information: Female patient , 25 years of age, was diagnosed with infertility (What is infertility?) and. Puregon dosage: . During the same period patient was treated with BROMOCRIPTINE MESYLATE (View Bromocriptine Mesylate Review and Bromocriptine Mesylate Label ), PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ), VAGINAL PROGESTERONE (View Vaginal Progesterone Review and Vaginal Progesterone Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

5008892-2 | Abdominal Distension, Abdominal Tenderness, Asthenia, Brain Herniation, Brain Oedema, Cerebral Artery Occlusion, Cerebrovascular Accident, Discomfort, Fatigue
Adverse event was reported on May 10, 2006 by a Female patient taking Puregon (View Usage) (Dosage: 150 Iu Daily) was diagnosed with infertility (What is infertility?) and. Location: UNITED STATES , 31 years of age, Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal tenderness, asthenia, brain herniation, brain oedema, cerebral artery occlusion, cerebrovascular accident, discomfort, fatigue. During the same period patient was treated with ORGALUTRAN (3 Df Daily) (View Orgalutran Review and Orgalutran Label ).

4818596-4 | Abdominal Pain Lower, Abortion Missed, Adnexa Uteri Mass, Blood Urine Present, Constipation, Ectopic Pregnancy, Multiple Pregnancy, Ovarian Mass, Peritoneal Haemorrhage
on Oct 17, 2005 Female patient from UNITED STATES , 30 years of age, was treated with Puregon (View Usage). Patient had the following side effects: abdominal pain lower, abortion missed, adnexa uteri mass, blood urine present, constipation (What is constipation?), ectopic pregnancy, multiple pregnancy, ovarian mass, peritoneal haemorrhage. Puregon dosage: Df. During the same period patient was treated with PREGNYL (Df) (View Pregnyl Review and Pregnyl Label ). Patient was hospitalized.

4665268-5 | Abortion Spontaneous Incomplete
on May 05, 2005 Female patient from , 42 years of age, was diagnosed with in vitro fertilisation and was treated with Puregon (View Usage). After Puregon was administered, patient had the following side effects: abortion spontaneous incomplete. Puregon dosage: Used For Approximately 7-10 Days.

4660240-3 | Ovarian Hyperstimulation Syndrome, Pulmonary Embolism
Patient was taking Puregon (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian hyperstimulation syndrome, pulmonary embolism (What is pulmonary embolism?) on Mar 11, 2005 from Additional patient health information: Female patient , 28 years of age, weighting 125.0 lb, was diagnosed with ovulation induction and. Puregon dosage: . During the same period patient was treated with CHORIONIC GONADOTROPIN (Df Daily) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), REPRONEX (75 Iu Qd Intramuscular) (View Repronex Review and Repronex Label ). Patient was hospitalized.

4520193-5 | Anxiety, Pulmonary Embolism, Venous Thrombosis Limb
Adverse event was reported on Jul 06, 2004 by a Female patient taking Puregon (View Usage) (Dosage: 150 Iu Daily) was diagnosed with infertility female and. Location: , 31 years of age, weighting 140.3 lb, Patient had the following side effects: anxiety (What is anxiety?), pulmonary embolism (What is pulmonary embolism?), venous thrombosis limb. During the same period patient was treated with PEPCID (View Pepcid Review and Pepcid Label ), VALTRAX (View Valtrax Review and Valtrax Label ), REPRONEX (View Repronex Review and Repronex Label ), HCG (View Hcg Review and Hcg Label ), BIRTH CONTROL PILLS (View Birth Control Pills Review and Birth Control Pills Label ). Patient was hospitalized and became disabled.